vimarsana.com
Home
Live Updates
Unity Biotechnology : Phase 2 ENVISION Program Update Call P
Unity Biotechnology : Phase 2 ENVISION Program Update Call P
Unity Biotechnology : Phase 2 ENVISION Program Update Call Presentation
Arshad M. Khanani MD, MA, FASRS Director of Clinical Research at Sierra Eye Associates
Anirvan Ghosh, CEO Jamie Dananberg, CMO Lynne Sullivan, CFO
... | March 27, 2023
Related Keywords
Jamie Dananberg ,
Anirvan Ghosh ,
Arshadm Khanani ,
Lynne Sullivan ,
Exchange Commission On ,
Drug Administration ,
Nasdaq ,
Unity Biotechnology Inc ,
Clinical Development Plan ,
Exchange Commission ,
Clinical Research ,
Sierra Eye ,
Unity Biotechnology ,
Study Data ,
Disease Pathology ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Irshad ,
Dhanani ,
Ohasrs ,
Director ,
F ,
Linical ,
Research ,
It ,
Sierra ,
Eye ,
Nirvan ,
Ceo ,
Jamie ,
Imo ,
Ynne Ubx Us91381u2006 ,